SEC Filing Timeline
8-KMay 28, 2026
Shareholder vote results · Items 5.07
8-KMay 13, 2026
Earnings release · Items 2.02,9.01
10-QMay 13, 2026
Quarterly report
DEF 14AApr 15, 2026
Proxy statement
10-KMar 24, 2026
Annual report
8-KMar 24, 2026
Earnings release · Items 2.02,9.01
8-KFeb 19, 2026
Material agreement · Items 1.01,7.01,9.01
424B5Feb 19, 2026
Prospectus / offering
424B5Feb 17, 2026
Prospectus / offering
8-KFeb 17, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
8-KJan 07, 2026
Material agreement · Items 1.01,2.03,9.01
Recent News (Finnhub)
Is COMPASS Pathways (CMPS) Quietly Recalibrating Its Commercialization Strategy With This Board Appointment?
FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-…
Compass Pathways: A Psychedelics Story
Compass Pathways Elects Kathleen Tregoning to Board of Directors
Compass Pathways: A Trip Worth Taking Before The FDA Verdict
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026